2012
DOI: 10.1016/j.bmcl.2012.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Verrulactones A and B, new inhibitors of Staphylococcus aureus enoyl-ACP reductase produced by Penicillium verruculosum F375

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 15 publications
0
9
0
Order By: Relevance
“…The biosynthesis of 7 and 8 was proposed in 2012, while their biosynthetic enzyme SnPKS19 was identified from a wheat pathogen Parastagonospora nodorum ( Kim et al, 2012 ; Chooi et al, 2015 ). Therefore, the biosynthesis of dibenzo-α-pyrone 5 – 8 in Diaporthe sp.…”
Section: Resultsmentioning
confidence: 99%
“…The biosynthesis of 7 and 8 was proposed in 2012, while their biosynthetic enzyme SnPKS19 was identified from a wheat pathogen Parastagonospora nodorum ( Kim et al, 2012 ; Chooi et al, 2015 ). Therefore, the biosynthesis of dibenzo-α-pyrone 5 – 8 in Diaporthe sp.…”
Section: Resultsmentioning
confidence: 99%
“…The known compounds were identified as 4‐hydroxyalternariol‐9‐methyl ether ( 1 ), 27 (−)‐talaroflavone ( 4a ), 26 altenuene ( 5 ), 28 altertoxin I ( 6 ), 29 and verrulactone A ( 8 ) (Figure 4). 30 …”
Section: Resultsmentioning
confidence: 99%
“…Studies in the past have established that InhA is the primary molecular target for INH which has been the frontline drug for over 40 years used in the treatment of TB. The INH‐NADH adduct functions as a potent inhibitor of InhA and the well‐known non‐selective InhA inhibitors diazoborines and triclosan, InhA direct inhibitors, pyrrole derivatives and piperazines have all been reported to exhibit in vivo as well as in vitro antitubercular activities.…”
Section: Resultsmentioning
confidence: 99%